These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31479011)

  • 21. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
    Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M
    Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Endophthalmitis Caused by
    Singh S; Patel CV; Kishore K
    Case Rep Ophthalmol; 2017; 8(3):510-514. PubMed ID: 29282402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
    Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
    Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracrystalline Ozurdex
    Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
    Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Chihaia M; Richardson-May J; Al-Saffar L; Kettledas H; Rashid M
    Access Microbiol; 2020; 2(6):acmi000124. PubMed ID: 32974588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.
    Adán A; Pelegrín L; Rey A; Llorenç V; Mesquida M; Molins B; Ríos J; Keller J
    Retina; 2013; 33(7):1435-40. PubMed ID: 23514796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal Dexamethasone Implant for the Treatment of Postoperative Macular Edema.
    Klamann A; Böttcher K; Ackermann P; Geerling G; Schargus M; Guthoff R
    Ophthalmologica; 2016; 236(4):181-185. PubMed ID: 27915343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ACUTE ATYPICAL ENDOPHTHALMITIS FOLLOWING INTRAVITREAL SUSTAINED-RELEASE DEXAMETHASONE IMPLANT: A CASE SERIES.
    Chin YYB; Yeo TH; Bakthavatsalu M; Zhou WT; Wagle AM; Gopal L; Lim TH
    Retin Cases Brief Rep; 2024 Mar; 18(2):155-158. PubMed ID: 36730427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema.
    Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U;
    Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony.
    Kong X; Psaras C; Stewart JM
    Ophthalmol Retina; 2019 Nov; 3(11):993-997. PubMed ID: 31371197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone.
    Small KW; Chan CK; Silva-Garcia R; Walsh TJ
    Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of 342 cases of endogenous bacterial endophthalmitis.
    Jackson TL; Paraskevopoulos T; Georgalas I
    Surv Ophthalmol; 2014; 59(6):627-35. PubMed ID: 25113611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reactivation of Latent Toxoplasmosis Following Dexamethasone Implant Injection.
    Olson DJ; Parhiz AT; Wirthlin RS
    Ophthalmic Surg Lasers Imaging Retina; 2016 Nov; 47(11):1050-1052. PubMed ID: 27842200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute endophthalmitis caused by Staphylococcus lugdunesis after intravitreal bevacizumab (Avastin) injection.
    Alkuraya HS; Al-Kharashi AS; Alharthi E; Chaudhry IA
    Int Ophthalmol; 2009 Oct; 29(5):411-3. PubMed ID: 18528639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cauterization of Ozurdex wound for the prevention of scleral leakage in vitrectomized eyes.
    Furino C; Recchimurzo N; Boscia F; Alessio G
    Eur J Ophthalmol; 2018 May; 28(3):341-343. PubMed ID: 29108392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brevibacterium casei endophthalmitis after intravitreal dexamethasone implant.
    Olate-Pérez A; Díaz-Céspedes RA; Ruíz-Del-Río N; Hernández-Pérez D; Duch-Samper A
    Arch Soc Esp Oftalmol (Engl Ed); 2021 Oct; 96(10):549-551. PubMed ID: 34620485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reliability and safety of intravitreal Ozurdex injections. The ZERO study].
    Schmitz K; Maier M; Clemens CR; Höhn F; Wachtlin J; Lehmann F; Bertelmann T; Rüdiger K; Horn M; Bezatis A; Spital G; Meyer CH;
    Ophthalmologe; 2014 Jan; 111(1):44-52. PubMed ID: 23559321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal Dexamethasone Implant for Treatment of Sarcoidosis-Related Uveitis.
    Kim M; Kim SA; Park W; Kim RY; Park YH
    Adv Ther; 2019 Aug; 36(8):2137-2146. PubMed ID: 31140122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.